Succinyl-Beta-Cyclodextrin

Succinyl-Beta-Cyclodextrin

Our customer services representatives are available 24 hours a day, from Monday to Sunday.

CONTACT US
Online Inquiry
Verification code
Succinyl-Beta-Cyclodextrin
INQUIRY
Succinyl-Beta-Cyclodextrin

Abbreviation SuBCD

Catalog CD-DR05

Cyclodextrin Type Cyclodextrin Derivatives

Packaging 1 g, 10 g

Quality Fine chemical grade

Storage Condition Store in an airtight container at room temperature.

Availability In stock

*On-demand pack size is available, please contact us for multi-kilograms pack sizes.

Description

Parameters

Applications

Related Products

Case Study

Product Description

Succinyl-Beta-Cyclodextrin (SBCD) represents a versatile derivative of beta-cyclodextrin. It is synthesized through the modification of beta-cyclodextrin by introducing succinyl groups (-CO-CH2-CH2-COOH) to the primary and secondary hydroxyl groups on the cyclodextrin ring. This structural alteration significantly enhances the molecule's physicochemical properties, making it a powerful agent for various complexation and solubilization applications.

Basic Information

Molecular FormulaC42H70-nO35·(C4H5O3)n
Formula Weight1135.0+n·(100.1)
Possible ImpuritiesBeta-cyclodextrin, succinic acid
Solubility (in 100 cm3 solvent, at 25 °C)Water: >50 g, Methanol: >50 g, Chloroform:<1 g

Detailed Information

Physical & Chemical Properties

Appearancewhite to slight yellow powder
Average degree of substitution (n)2.0-5.0
Purity>90%
Loss on drying<10%

Impurities

Residual succinic acid<3%
Residual beta-cyclodextrin<5%

Key Properties

  • The introduction of succinyl groups increases the hydrophilicity of the molecule, leading to improved solubility in aqueous systems.
  • SBCD has a remarkable capacity to form inclusion complexes with hydrophobic molecules, enhancing their solubility, stability, and bioavailability.
  • Exhibits low toxicity and high biocompatibility, making it suitable for pharmaceutical and biomedical applications.
  • Improved thermal and chemical stability compared to native beta-cyclodextrin.

Synthesis of Succinyl-Beta-Cyclodextrin

The synthesis of Succinyl-Beta-Cyclodextrin involves the reaction of beta-cyclodextrin with succinic anhydride under controlled conditions. This process typically includes:

A. Activation of Cyclodextrin: Beta-cyclodextrin is dissolved in an appropriate solvent (e.g., dimethyl sulfoxide or water).

B. Succinylation Reaction: Succinic anhydride is added to the solution under alkaline conditions, promoting the nucleophilic substitution of hydroxyl groups by succinyl groups.

C. Purification: The product is purified through precipitation, dialysis, or chromatographic techniques to remove unreacted reagents and by-products.

Fig.1 Synthesis method of succinyl-β-cyclodextrinFigure 1. Synthetic route to Suc-β-CD[1].

Applications

Pharmaceutical Industry

SBCD is widely utilized in the formulation of advanced drug delivery systems due to its superior ability to enhance the solubility, stability, and bioavailability of poorly water-soluble drugs. It is particularly valuable in:

  • Oral Drug Delivery - Enhances the dissolution rate of hydrophobic drugs, leading to improved absorption and therapeutic efficacy.
  • Parenteral Formulations - Used in injectable formulations to stabilize and solubilize drugs that are otherwise challenging to deliver intravenously.
  • Controlled Release Systems - Facilitates the design of controlled and targeted release formulations, allowing for sustained drug action.

Case Study: Anticancer Drugs

SBCD has been effectively employed in the solubilization of anticancer drugs such as paclitaxel and docetaxel, which are notoriously difficult to deliver due to their low solubility. SBCD complexes improve drug bioavailability, reduce systemic toxicity, and enhance therapeutic outcomes.

Food and Beverage Industry

SBCD's ability to form inclusion complexes extends to food and beverage applications, where it is used as an encapsulating agent for flavors, fragrances, and essential oils. This modification:

  • Enhances the stability of sensitive compounds against oxidation and light degradation.
  • Improves the solubility of hydrophobic additives in aqueous-based products.
  • Acts as a carrier for active ingredients, improving their release profile.

Cosmetics and Personal Care

In the cosmetics industry, SBCD is utilized in formulations to enhance the stability and delivery of active ingredients such as vitamins, antioxidants, and fragrances. Its inclusion capabilities help protect sensitive compounds from degradation, ensuring longer-lasting efficacy in products.

Environmental Applications

SBCD's complexation properties are harnessed in environmental applications for the removal of contaminants such as pesticides, heavy metals, and organic pollutants. Its ability to form stable complexes with hydrophobic pollutants enhances their solubility and facilitates easier removal through various remediation processes.

Alfa Chemistry offers high-purity succinyl-alpha-cyclodextrin manufactured under stringent quality control processes, ensuring reliable performance and consistency in every batch. For further inquiries or product details, please contact Alfa Chemistry, your trusted partner in chemical innovation.

Reference

  1. Shinde, V.V.; et al. Succinyl-β-cyclodextrin-driven synthesis of a nitrogen-fused five-ring heterocycle using GBB-based [4+1] cycloaddition via supramolecular host-guest interactions. Tetrahedron. 2019, 75(6): 778-783.

Case Study

Succinyl-β-Cyclodextrin for the Functionalization of Gold Biochips in Lyme Disease Immunoassay

Succinyl-Beta-cyclodextrin modified gold biochip improved seroimmunological detection sensitivity for Lyme diseaseYe L, et al. Analytica Chimica Acta, 2017, 953, 48-56.

Succinyl-beta-cyclodextrin (succinyl-β-CD) was employed to modify gold biochips for enhanced seroimmunological detection of Lyme disease. The chemical modification process began with the activation of succinyl-β-CD by carbodiimide chemistry using EDC (50 mM) and NHS (430 mM) in aqueous solution at 4 °C for 2 hours. Simultaneously, gold slides were functionalized with 16-amino-1-hexadecanethiol (0.8 mM in ethanol) to generate an aminated surface. These aminated slides were subsequently immersed in the activated succinyl-β-CD solution at room temperature under dark conditions for 24 hours to achieve covalent immobilization via amide bond formation. Post-reaction, slides were washed and dried under nitrogen stream.

The resulting succinyl-β-CD modified gold surface provided a host-guest interaction platform with enhanced affinity towards the VlsE antigen, enabling highly sensitive detection (LOD: 0.39 μg/mL) of anti-VlsE IgG antibodies via fluorescence assays. Specificity was validated using immunological blocking, and strong correlation with ELISA (R² = 0.904) confirmed the platform's analytical reliability.

Succinyl-β-Cyclodextrin for the Synthesis of Indazolo[3',2':2,3]imidazo[1,5-c]quinazolin-6(5H)-one via GBB-Based Cycloaddition

Succinyl-beta-cyclodextrin–driven synthesis of a nitrogen-fused five-ring heterocycle using GBB-based [4 + 1] cycloaddition via supramolecular host–guest interactionsShinde V. V, et al. Tetrahedron, 2019, 75(6), 778-783.

Succinyl-beta-cyclodextrin (Suc-β-CD) was utilized as a supramolecular organic acid catalyst in the Groebke–Blackburn–Bienaymé (GBB) multicomponent reaction to synthesize the nitrogen-fused heterocycle indazolo[3',2':2,3]imidazo[1,5-c]quinazolin-6(5H)-one (IIQ). This method showcases the efficacy of Suc-β-CD in promoting [4 + 1] cycloaddition via host–guest interactions, offering an atom-economical and environmentally benign protocol. In a typical procedure, a mixture of isatin (1 mmol), 1H-indazol-3-amine (1 mmol), and isocyanide (1 mmol) was reacted in 5 mL of water containing 1 mol% Suc-β-CD. The reaction mixture was stirred at 100 °C, and the progress was monitored using TLC with DCM/methanol (95:5) as the mobile phase. Upon completion, the precipitated IIQ product was isolated by filtration and washed with water. The catalyst was effectively recovered from the aqueous filtrate through acetone-induced precipitation, followed by washing and vacuum drying at 60 °C. The recyclability of Suc-β-CD was confirmed through repeated catalytic cycles with consistent performance.

Succinyl-β-Cyclodextrin for Enhanced Specificity in DNA Mismatch Detection Using DiSC2(5) Dye

Fast and easy colorimetric tests for single mismatch recognition by PNA–DNA duplexes with the diethylthiadicarbocyanine dye and succinyl-beta-cyclodextrinTedeschi T, et al. Journal of Biochemical and Biophysical Methods, 2007, 70(5), 735-741.

Succinyl-β-cyclodextrin (Succ-β-CyD) was employed to improve the specificity of a visual DNA mismatch detection system based on the 3,3'-diethylthiacarbocyanine iodide (DiSC2(5)) dye. While DiSC2(5) typically aggregates on fully matched PNA–DNA duplexes, producing a visible color shift from blue to purple, its nonspecific aggregation on mismatched duplexes and even free PNA strands has limited its analytical precision. The introduction of Succ-β-CyD effectively suppressed these nonspecific interactions.

Experimental protocols involved preparing 5 μM solutions of single-stranded PNA or PNA–DNA duplexes in phosphate buffer (10 mM, 100 mM NaCl, pH 7). Duplexes were annealed by heating to 90 °C for 5 minutes followed by slow cooling to room temperature. DiSC2(5) was then added at 15 μM concentration to the prepared solutions, either in the presence or absence of Succ-β-CyD. Absorption spectra were recorded immediately post-addition at controlled temperatures (15–25 °C). Circular dichroism (CD) spectra and melting temperature (Tm) measurements were also conducted to assess dye binding behavior and duplex stability.

Succinyl-β-Cyclodextrin for the Enantioselective Hydrolysis of (R,S)-Flurbiprofen Ethyl Ester

Lipase-catalyzed production of optically active (S)-flurbiprofen in aqueous phase reaction system containing chiral succinyl Beta-cyclodextrinShin G-S, et al. Journal of Molecular Catalysis B: Enzymatic, 2005, 33(3-6), 93-98.

Succinyl-beta-cyclodextrin (suβ-CD) was employed as a chiral selector and phase dispersion agent to facilitate the enantioselective hydrolysis of (R,S)-flurbiprofen ethyl ester ((R,S)-FEE) in an aqueous reaction system catalyzed by Candida rugosa lipase. The process exploited the ability of suβ-CD to form selective inclusion complexes with the enantiomers of FEE, enhancing the substrate's aqueous solubility and enabling effective chiral discrimination.

In the optimized procedure, 50 mM (R,S)-FEE was first dissolved in sodium phosphate buffer (pH 7.0) and mixed with 100 mM suβ-CD. Ultrasonication for 1 minute facilitated the formation of the inclusion complex. Subsequently, 600 units of C. rugosa lipase per mmol of FEE were introduced, and the reaction was maintained at 37 °C with shaking at 300 rpm for 72 hours. A separate set of reactions at higher concentrations—500 mM (R,S)-FEE and 1000 mM suβ-CD—was also evaluated, yielding a remarkable enantiomeric excess (ee) of 0.98 and conversion yield of 0.48.

It should be noted that our our products and services are for research use only, not for clinical use.